Aureusimine B

CAS No. 170713-71-0

Aureusimine B( 3-(1-Methylethyl)-6-(phenylmethyl)-2(1H)-pyrazinone )

Catalog No. M28144 CAS No. 170713-71-0

Aureusimine B, a Calpain inhibitor, is produced by Staphylococcus aureus biofilms and could be a potential biomarker for S. aureus biofilm-based infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 167 In Stock
2MG 120 In Stock
5MG 187 In Stock
10MG 283 In Stock
25MG 452 In Stock
50MG 631 In Stock
100MG 848 In Stock
200MG 1107 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aureusimine B
  • Note
    Research use only, not for human use.
  • Brief Description
    Aureusimine B, a Calpain inhibitor, is produced by Staphylococcus aureus biofilms and could be a potential biomarker for S. aureus biofilm-based infections.
  • Description
    Aureusimine B, a Calpain inhibitor, is produced by Staphylococcus aureus biofilms and could be a potential biomarker for S. aureus biofilm-based infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-(1-Methylethyl)-6-(phenylmethyl)-2(1H)-pyrazinone
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Cysteine Protease
  • Recptor
    CaSR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    170713-71-0
  • Formula Weight
    228.295
  • Molecular Formula
    C14H16N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)c1ncc(Cc2ccccc2)[nH]c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kumar S, et al. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone. 2010 Feb;46(2):534-42.
molnova catalog
related products
  • Z-Lys-OH

    Z-Lys-OH is a competitive inhibitor of papain, a lysine derivative.

  • Liraglutide

    Liraglutide is a long-acting GLP-1 receptor agonist.

  • Aurantiamide acetate

    Aurantiamide acetate was isolated from the fermentation broth of Aspergillus penicilloides for the first time. Aurantiamide acetate is a selective and orally active cathepsin inhibitor. Aurantiamide acetate has anti-inflammatory activities and can be used for the study of inflammatory diseases.